[1]Patent:US2016/362408,2016,A1,.Locationinpatent:Paragraph0455;0456;0457;0458;0459
[1]JournalofOrganicChemistry,2013,vol.78,#7,p.3400-3404
[2]BioorganicandMedicinalChemistryLetters,2018,
129488-10-4
219503-81-8
801315-74-2
574729-25-2
1426854-71-8
1426854-74-1
118358-38-6 | FMOC-L-SER(BETA-D-GLCAC4)-OH | AA008UY4 | MFCD03452820
1134333-99-5 | 4-(Hydroxymethyl)-5-methylisoxazole-3-carboxylic acid | AA008V40 | MFCD12030889
1208075-25-5 | 2-Chloro-6-fluorobenzene-1-sulfonyl chloride | AA008VAU | MFCD12026157
10486-51-8 | 4-Chlorosulfonyl-benzoic acid ethyl ester | AA008VFY | MFCD00121815
1033078-12-4 | (R,S)-N2-Nitroso-Anabasine N'-β-D-Glucuronide | AA008VKZ | MFCD28898584
1175129-26-6 | delta-5(6)-Didehydronorethindrone acetate | AA008VTX | MFCD11114037
1061358-71-1 | 2-((2-Chloro-5-(trifluoromethyl)pyridin-4-yl)amino)-N-methylbenzamide | AA008W0Y | MFCD30186653
105310-28-9 | cis-2-(AMinoMethyl)-1-phenylcyclopropanecarboxylic Acid Hydrochloride | AA008W9C | MFCD01735738
1189730-34-4 | Glycerol 1,2-Dichlorohydrin-d5 | AA008WKU | MFCD28898670
1006381-03-8 | 1,3,2-Dioxathiolane, 4-methyl-, 2,2-dioxide, (4r)- | AA008WSI | MFCD26131319
1099057-19-8
1415719-67-3
1286703-16-9
868982-22-3
1421456-98-5